滿地(01400.HK)急彈2.5倍曾逼近52周高位 擬進行口罩原材料及成品生產
滿地科技(01400.HK)擬計劃進行口罩原材料及成品之生產,以應對內地當前新冠肺炎疫情,該股今早一度飆升4.8倍至0.5元,接近52周高位0.52元遇阻,彈幅急速收窄至2.5倍,報0.3元,股價重越牛熊線(0.244元),一向稀疏成交激增至1,770萬股,創逾七個月高。
滿地科技主要從事紡織業務,公司表現,面對當前新冠肺炎疫情,醫療防護物資嚴重短缺的局面,公司嚮應當地政府的號召,將積極考慮組織現有之生產資源,改造和添加口罩生產設備,在湖北及福建兩大紡織生產基地,擬計劃進行口罩原材料及成品之生產。(sz/k)~
阿思達克財經新聞
網址: www.aastocks.com
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.